Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3516887 | 0.85 | CTSD (0.47) | TP53POLBMAPTALDH1A1GAA | |
| SCHEMBL3519120 | 0.83 | TP53 (0.43) | TP53HDAC3HDAC1HDAC2POLB | |
| SCHEMBL15031308 | 0.83 | CA1 (0.44) | TP53HDAC3HDAC1HDAC2MAPT | |
| SCHEMBL13135884 | 0.80 | MEN1 (0.42) | TP53POLBMAPTTDP1ALDH1A1 | |
| SCHEMBL13115558 | 0.78 | TP53 (0.40) | TP53HDAC3HDAC1HDAC2TDP1 | |
| SCHEMBL15031355 | 0.75 | CTSD (0.45) | TP53POLBMAPTALDH1A1GAA | |
| SCHEMBL15031305 | 0.71 | TP53 (0.53) | TP53HDAC3HDAC1HDAC2TDP1 | |
| SCHEMBL3521719 | 0.71 | CTSD (0.43) | TP53MAPTALDH1A1HPGDKMT2A | |
| SCHEMBL13761422 | 0.70 | TP53 (0.68) | TP53HDAC3HDAC1HDAC2MAPT | |
| SCHEMBL10793237 | 0.69 | TP53 (0.71) | TP53HDAC3HDAC1HDAC2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8466238-B2 | Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays | MITSUI CHEMICALS, INC. (JP) | 2013-06-18 | — | — | US | disclosed |
| US-8466238-B2 | Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays | MITSUI CHEMICALS, INC. (JP) | 2013-06-18 | — | — | US | disclosed |
| US-20100253213-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | MITSUI CHEMICALS, INC (JP) | 2010-10-07 | — | — | US | disclosed |
| EP-2199313-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONATING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | Mitsui Chemicals, Inc. (JP) | 2010-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100253213-A1 | LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS | LTA4H, EPHX2, EPHX1 | TP53 3840/4885HDAC3 1865/4885HDAC1 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.